Nakazawa Hideyuki, Makishima Hideki, Ito Toshiro, Ota Hiroyoshi, Momose Kayoko, Sekiguchi Nodoka, Yoshizawa Kaname, Akamatsu Taiji, Ishida Fumihiro
1. Department of Internal Medicine, Division of Hematology, Shinshu University School of Medicine, 3-1-1 Asahi Matsumoto, Japan 390-8621;
2. Department of Biomedical Laboratory Sciences, School of Health Sciences, Shinshu University School of Medicine, 3-1-1 Asahi Matsumoto, Japan 390-8621;
Int J Med Sci. 2014 Jun 3;11(8):819-23. doi: 10.7150/ijms.8854. eCollection 2014.
The prevalence of celiac disease (CD) among Japanese population has been unknown, whereas it has been increasingly recognized in the US and in the European countries. The aim of the present study is to identify possible cases with CD among Japanese population and clarify the relevance of screening for the disease. We conducted a serologic screening for the disease among 710 Japanese patients and 239 healthy volunteers at a local tertiary teaching hospital, using an anti-tissue transglutaminase IgA (TTG-IgA) test, and histological examination of the small intestines from the TTG-IgA positive subjects. There were no TTG-IgA positive sera among the healthy volunteers. Twenty of the patients (2.8%), including eight with malignant lymphoma, were tested positive for TTG-IgA. The histological examination of the eleven patients among those with positive TTG-IgA, seven showed villous atrophy and partial lymphocytes infiltration in the mucosa, which could be compatible to mucosal changes observed in CD. Five of them had non-Hodgkin lymphoma in the gastrointestinal tracts. Serologic tests using TTG-IgA might be relevant to screen for those with undiagnosed CD among Japanese population.
日本人群中乳糜泻(CD)的患病率尚不清楚,而在美国和欧洲国家,该病已得到越来越多的认识。本研究的目的是在日本人群中识别可能患有CD的病例,并阐明该疾病筛查的相关性。我们在当地一家三级教学医院,对710名日本患者和239名健康志愿者进行了该疾病的血清学筛查,采用抗组织转谷氨酰胺酶IgA(TTG-IgA)检测,并对TTG-IgA阳性受试者的小肠进行组织学检查。健康志愿者中没有TTG-IgA阳性血清。20名患者(2.8%),包括8名患有恶性淋巴瘤的患者,TTG-IgA检测呈阳性。对TTG-IgA阳性的11名患者进行组织学检查,其中7名显示绒毛萎缩和黏膜部分淋巴细胞浸润,这与CD中观察到的黏膜变化相符。其中5名患者在胃肠道患有非霍奇金淋巴瘤。使用TTG-IgA进行血清学检测可能有助于筛查日本人群中未确诊的CD患者。